Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lior Golumb"'
Autor:
Justin H. Hwang, Ji-Heui Seo, Michael L. Beshiri, Stephanie Wankowicz, David Liu, Alexander Cheung, Ji Li, Xintao Qiu, Andrew L. Hong, Ginevra Botta, Lior Golumb, Camden Richter, Jonathan So, Gabriel J. Sandoval, Andrew O. Giacomelli, Seav Huong Ly, Celine Han, Chao Dai, Hubert Pakula, Anjali Sheahan, Federica Piccioni, Ole Gjoerup, Massimo Loda, Adam G. Sowalsky, Leigh Ellis, Henry Long, David E. Root, Kathleen Kelly, Eliezer M. Van Allen, Matthew L. Freedman, Atish D. Choudhury, William C. Hahn
Publikováno v:
Cell Reports, Vol 29, Iss 8, Pp 2355-2370.e6 (2019)
Summary: Androgen-receptor (AR) inhibitors, including enzalutamide, are used for treatment of all metastatic castration-resistant prostate cancers (mCRPCs). However, some patients develop resistance or never respond. We find that the transcription fa
Externí odkaz:
https://doaj.org/article/40f707e6f0e3479da1c48a8eaa450461
Autor:
Jonathan So, Kathleen Kelly, Ole Gjoerup, David E. Root, Alexander T. M. Cheung, Camden Richter, Adam G. Sowalsky, Ginevra Botta, Matthew L. Freedman, Ji Li, Eliezer M. Van Allen, Michael L. Beshiri, Federica Piccioni, Justin H. Hwang, Henry W. Long, Andrew L. Hong, Andrew O. Giacomelli, Celine Han, Seav Huong Ly, Massimo Loda, Hubert Pakula, Anjali V. Sheahan, Atish D. Choudhury, Chao Dai, Stephanie A. Wankowicz, David Liu, Ji-Heui Seo, Gabriel J. Sandoval, Lior Golumb, Leigh Ellis, William C. Hahn, Xintao Qiu
Publikováno v:
Cell reports
Cell Reports, Vol 29, Iss 8, Pp 2355-2370.e6 (2019)
Cell Reports, Vol 29, Iss 8, Pp 2355-2370.e6 (2019)
SUMMARY Androgen-receptor (AR) inhibitors, including enzalutamide, are used for treatment of all metastatic castration-resistant prostate cancers (mCRPCs). However, some patients develop resistance or never respond. We find that the transcription fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41fc794dbd7bf5631a9a572f70820d99
https://pubmed.ncbi.nlm.nih.gov/31747605
https://pubmed.ncbi.nlm.nih.gov/31747605